Jedzada Maneechavakajorn
Rajavithi Hospital(TH)
Publications by Year
Research Areas
Monoclonal and Polyclonal Antibodies Research, Glycosylation and Glycoproteins Research, Immunotherapy and Immune Responses, Peptidase Inhibition and Analysis, HER2/EGFR in Cancer Research
Most-Cited Works
- → A randomized, double-blind, placebo-controlled study evaluating the efficacy of combination olanzapine, ondansetron and dexamethasone for prevention of chemotherapy-induced nausea and vomiting in patients receiving doxorubicin plus cyclophosphamide(2019)39 cited
- Quality of life, Functional Assessment of Cancer Therapy-General.(2001)
- Prognostic factors for survival in colorectal cancer patients.(2010)
- → Clonal Evolutionary Analysis during HER2 Blockade in HER2-Positive Inflammatory Breast Cancer: A Phase II Open-Label Clinical Trial of Afatinib +/- Vinorelbine(2016)36 cited
- → Phase II study of paclitaxel and carboplatin for advanced non-small-cell lung cancer(1999)21 cited
- → Open-label, phase IIa study of dabrafenib plus trametinib in East Asian patients with advanced BRAF V600-mutant cutaneous melanoma(2020)19 cited
- Survival and prognostic factors of stage I-III breast cancer.(2013)
- Prognostic factors for survival in advanced non-small cell lung cancer.(2004)
- → A phase Ib study of IMU-131 HER2/neu peptide vaccine plus chemotherapy in patients with HER2/neu overexpressing metastatic or advanced adenocarcinoma of the stomach or gastroesophageal junction.(2019)3 cited
- → Comprehensive results of a phase Ib study with a HER2/neu B-cell peptide vaccine administered with cisplatin and 5-fluorouracil or capecitabine chemotherapy show safety, immunogenicity and clinical response in patients with HER2/Neu overexpressing advanced gastric cancer(2019)3 cited